Portfolio of Genetic Testing Stocks

Here are 6 genetic testing stocks.

6 Genetic Testing Stocks

Name & Return

& Snapshot

Cancer Genetics CGIX
Exact Sciences EXAS
Genetic Technologies Ltd GENE
Invitae NVTA
Natera NTRA
Veracyte VCYT
Display Price Chart for each stock.
Display Dividend Chart for each stock.

Portfolio Values

To inspect the performance of the Genetic Testing Stocks portfolio, see the chart below. Portfolio values are computed using monthly closes for stocks from Alpha Vantage.

All 6 stocks are included in the portfolio computations. The current value of the portfolio assumes that $1,666.67 was invested in each stock at its closing monthly price for the first date shown on the portfolio value chart below. All prices are adjusted for splits and dividends.

The current value of the $10,000 investment is $8,743. The percent return is -12.57%. The annualized return is -2.65%.

Portfolio Value Chart for Last 100 Daily Closes

Related Portfolios

Portfolio of Gene Editing (CRISPR) Stocks

Portfolio of Gene Therapy Stocks

Portfolio of Genomics Stocks

Portfolio of Stem Cell Stocks